Hepatocellular carcinoma (primer)
JM Llovet, RK Kelley, A Villanueva… - Nature Reviews …, 2021 - search.proquest.com
Liver cancer remains a global health challenge, with an estimated incidence of> 1 million
cases by 2025. Hepatocellular carcinoma (HCC) is the most common form of liver cancer …
cases by 2025. Hepatocellular carcinoma (HCC) is the most common form of liver cancer …
Cholangiocarcinoma—evolving concepts and therapeutic strategies
SI Ilyas, SA Khan, CL Hallemeier, RK Kelley… - Nature reviews Clinical …, 2018 - nature.com
Cholangiocarcinoma is a disease entity comprising diverse epithelial tumours with features
of cholangiocyte differentiation: cholangiocarcinomas are categorized according to …
of cholangiocyte differentiation: cholangiocarcinomas are categorized according to …
Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology
AB Benson, MI D'Angelica, DE Abbott… - Journal of the National …, 2021 - jnccn.org
The NCCN Guidelines for Hepatobiliary Cancers focus on the screening, diagnosis, staging,
treatment, and management of hepatocellular carcinoma (HCC), gallbladder cancer, and …
treatment, and management of hepatocellular carcinoma (HCC), gallbladder cancer, and …
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …
Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma
A Bujold, CA Massey, JJ Kim, J Brierley… - Journal of Clinical …, 2013 - ascopubs.org
Purpose To describe outcomes of prospective trials of stereotactic body radiotherapy (SBRT)
for hepatocellular carcinoma (HCC). Patients and Methods Two trials of SBRT for patients …
for hepatocellular carcinoma (HCC). Patients and Methods Two trials of SBRT for patients …
External beam radiation therapy for primary liver cancers: an ASTRO clinical practice guideline
Purpose This guideline provides evidence-based recommendations for the indications and
technique-dose of external beam radiation therapy (EBRT) in hepatocellular carcinoma …
technique-dose of external beam radiation therapy (EBRT) in hepatocellular carcinoma …
Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic …
Purpose To evaluate the efficacy and safety of high-dose, hypofractionated proton beam
therapy for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) …
therapy for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) …
Radiation-associated liver injury
The liver is a critically important organ that has numerous functions including the production
of bile, metabolism of ingested nutrients, elimination of many waste products, glycogen …
of bile, metabolism of ingested nutrients, elimination of many waste products, glycogen …
NCCN guidelines insights: hepatobiliary cancers, version 1.2017
AB Benson, MI D'Angelica, DE Abbott… - Journal of the National …, 2017 - jnccn.org
The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for
cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel …
cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel …
Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced …
Background The synergy between locoregional therapies and immune checkpoint inhibitors
has not been investigated as conversion therapy for unresectable hepatocellular carcinoma …
has not been investigated as conversion therapy for unresectable hepatocellular carcinoma …